Advancing Pharmacoequity in Low- and Middle-Income Countries via Model Informed Drug Development. [PDF]
Clin Transl SciEnzama H +5 more
europepmc +1 more source
Physiologically based pharmacokinetic modeling of cefotaxime to inform pediatric dosing in renal impairment. [PDF]
Eur J Clin PharmacolRahim N, Sarfraz M, Wahajuddin M.
europepmc +1 more source
Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling. [PDF]
CPT Pharmacometrics Syst PharmacolChenel M +6 more
europepmc +1 more source
Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models to Investigate the Effect of CYP2D6 Polymorphism on Metoclopramide Systemic Exposure. [PDF]
Pharmaceuticals (Basel)Shahzad I +5 more
europepmc +1 more source
Innovative Clinical Pharmacology, Modeling, and Simulation Strategies for Accelerating Rare Disease Drug Development. [PDF]
J Clin PharmacolOberoi RK +8 more
europepmc +1 more source
Physiologically based pharmacokinetic modeling of tafenoquine and evaluation of transporter-mediated drug-drug interactions. [PDF]
Front PharmacolSantos LO +2 more
europepmc +1 more source
Integration of Machine Learning With PBPK and QSAR Modeling Approaches to Facilitate Drug Discovery and Development. [PDF]
CPT Pharmacometrics Syst PharmacolChen X, Lin Z.
europepmc +1 more source
Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets. [PDF]
ACS OmegaCarapeto GV +4 more
europepmc +1 more source
Exploring Tafamidis Effects Through PBPK-QSP Modelling. [PDF]
PharmaceuticsUlaszek S +3 more
europepmc +1 more source